BioCode CoV-2 Flu Plus Panel

About Applied BioCode

Applied BioCode is a private, commercial-stage diagnostics company specializing in multiplex syndromic panel testing for infectious diseases. Its proprietary BioCode platform, centered on barcoded magnetic beads, enables high-throughput, cost-effective detection of multiple pathogens on its MDx-3000 instrument system. The company has an FDA-cleared gastrointestinal panel and a portfolio of research-use and development-stage panels for respiratory, fungal, and sexually transmitted infections, positioning it in the growing multiplex molecular diagnostics market. Its value proposition emphasizes operational efficiency, flexibility in test ordering, and maximizing insurance reimbursement.

Therapeutic Areas

Other Respiratory Viral Infection Drugs